The Pleiotropic Roles of Cytokines in Chimeric Antigen Receptor T-cell Therapy

Area of Science:

• Immunology and Cancer Therapy

Background:

• Chimeric antigen receptor (CAR) T-cell therapy has transformed cancer treatment.
• Durable responses remain limited, and toxicities necessitate close monitoring.
• Cytokines are recognized as key mediators of CAR T-cell efficacy and toxicity.

Purpose of the Study:

• To review the role of cytokines in CAR T-cell therapy.
• To explore the paradoxical effects of specific cytokines (IFNγ, IL2, IL4, IL10) on CAR T-cell response and toxicity.
• To discuss factors influencing cytokine pleiotropy in this context.

Main Methods:

• Literature review of existing studies on cytokines and CAR T-cell therapy.
• Analysis of historical and recent findings on cytokine involvement.
• Discussion of factors contributing to cytokine pleiotropy.

Main Results:

• Cytokines significantly impact both the effectiveness and side effects of CAR T-cell therapy.
• Specific cytokines like IFNγ, IL2, IL4, and IL10 exhibit complex, sometimes contradictory, roles.
• Understanding these roles is crucial for optimizing therapeutic outcomes.

Conclusions:

• Cytokine modulation is a critical strategy for improving CAR T-cell therapy.
• Further research is needed to elucidate the pleiotropic effects of cytokines.
• Targeting cytokine pathways may enhance CAR T-cell efficacy and reduce toxicity.